Related Experiment Video
Updated: Aug 19, 2026

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
Published on: August 6, 2014
Human somatic mutation assays as biomarkers of carcinogenesis
P J Compton1, K Hooper, M T Smith
1Biomedical and Environmental Health Sciences, School of Public Health, University of California, Berkeley 94720.
Abstract:
This paper describes four assays that detect somatic gene mutations in humans: the hypoxanthine-guanine phosphoribosyl transferase assay, the glycophorin A assay, the HLA-A assay, and the sickle cell hemoglobin assay. Somatic gene mutation can be considered a biomarker of carcinogenesis, and assays for somatic mutation may assist epidemiologists in studies that attempt to identify factors associated with increased risks of cancer. Practical aspects of the use of these assays are discussed.
More Related Videos
Related Concept Videos
Mutations
Cancers Originate from Somatic Mutations in a Single Cell
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancers Originate from Somatic Mutations in a Single Cell
Mutagenicity and Carcinogenicity
Spontaneous and Induced Mutations

